ArticleJournal of market access & health policy2025

Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?

Claudio Jommi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.